Blockage of the IL-31 Pathway as a Potential Target Therapy for Atopic Dermatitis

Atopic dermatitis (AD), a pruritic, inflammatory chronic disease with multifactorial pathogenesis, has been a therapeutic challenge. Novel target treatments aim to reduce not only the immunologic dysfunction and microbiome dysbiosis but also the recovery of the damaged skin barrier. The current revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Orfali, Raquel Leao, Aoki, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961325/
https://www.ncbi.nlm.nih.gov/pubmed/36839897
http://dx.doi.org/10.3390/pharmaceutics15020577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961325/
https://www.ncbi.nlm.nih.gov/pubmed/36839897
http://dx.doi.org/10.3390/pharmaceutics15020577

Ejemplares similares